Hartford Financial Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Hartford Financial Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-86	Closed	-$3K	–	407
2021 Q2	$3K	Hold	86	–	–	﹤0.01%	359
2021 Q1	$4K	Hold	86	–	–	﹤0.01%	357
2020 Q4	$2K	Sell	86 -57	-40%	-$1.11K	﹤0.01%	344
2020 Q3	$8K	Hold	143	–	–	﹤0.01%	277
2020 Q2	$4K	Hold	143	–	–	﹤0.01%	311
2020 Q1	$3K	Hold	143	–	–	﹤0.01%	320
2019 Q4	$8K	Hold	143	–	–	﹤0.01%	303
2019 Q3	$8K	Hold	143	–	–	﹤0.01%	310
2019 Q2	$16K	Buy	143 +86	+151%	+$10.2K	0.01%	277
2019 Q1	$10K	Buy	+57	New	+$6.98K	﹤0.01%	302

Other funds holding ZSAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Hartford Financial Management's ZSAN Position: Q3 2021 in Review

Hartford Financial Management sold out of Zosano Pharma Corporation (ZSAN) in Q3 2021, closing a stake of 86 shares — an estimated $3K sold.

Hartford Financial Management first reported a position in ZSAN in Q1 2019 and held it in 10 quarters. The position peaked at $16K in Q2 2019. 32 funds tracked by Wall St. Rank hold ZSAN as of Q3 2021.

Hartford Financial Management reported no remaining Zosano Pharma Corporation position as of Q3 2021 after selling out during the quarter.
Hartford Financial Management sold 86 Zosano Pharma Corporation shares in Q3 2021, an estimated $3K.
Hartford Financial Management first reported a position in Zosano Pharma Corporation in Q1 2019 and held it in 10 quarters.
Hartford Financial Management's Zosano Pharma Corporation position peaked at $16K in Q2 2019.
32 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2021.

Based on Hartford Financial Management's 13F filing for Q3 2021, filed 29 Oct 2021.